- In March 2020, Dr. Reddy’s Laboratories Ltd. and its subsidiaries (collectively referred to as “Dr. Reddy’s”) announced the launch of Pyrimethamine Tablets USP, 25 mg. This product, approved by the U.S. Food and Drug Administration (USFDA), is a therapeutic equivalent and first-wave generic version of Daraprim (pyrimethamine) Tablets. It is the only AB-rated generic version of Daraprim® approved by the USFDA
